Remuzzi A, Remuzzi G
Mario Negri Institute for Pharmacological Research, Ospedali Riuniti di Bergamo, Italy.
Semin Nephrol. 1995 May;15(3):236-43.
Cyclooxygenase inhibitors have long been used in experimental studies as well as in clinical practice to reduce urinary protein excretion in proteinuric renal diseases. However, the mechanisms by which this treatment limits glomerular filtration of proteins are not fully elucidated. We will review the cellular and molecular mechanisms that regulate glomerular permselectivity and the experimental observations available on the effect of nonsteroidal anti-inflammatory drugs (NSAIDs) on these glomerular functions. The effects of NSAIDs on glomerular microcirculation will also be analyzed in comparison with another class of drugs used to lower proteinuria in nephrotic patients, the angiotensin converting enzyme inhibitors. Finally, we will analyze the relationship between urinary prostaglandins and thromboxane A2 and discuss the effects of modulating these hormones on glomerular functions.
环氧化酶抑制剂长期以来一直用于实验研究以及临床实践,以减少蛋白尿性肾脏疾病中的尿蛋白排泄。然而,这种治疗限制蛋白质肾小球滤过的机制尚未完全阐明。我们将综述调节肾小球选择性通透的细胞和分子机制,以及关于非甾体抗炎药(NSAIDs)对这些肾小球功能影响的现有实验观察结果。与另一类用于降低肾病患者蛋白尿的药物——血管紧张素转换酶抑制剂相比,还将分析NSAIDs对肾小球微循环的影响。最后,我们将分析尿前列腺素和血栓素A2之间的关系,并讨论调节这些激素对肾小球功能的影响。